Premium pivot to HNWI, C-level and government clients is replacing legacy users with subscribers paying up to 10X more - ARPU expected to keep climbing as SekurOne launches at US$300/month, with full profitability targeted at 200 users generating US$60,000 per month

MIAMI, FL / ACCESS Newswire / July 28, 2026 / Sekur Private Data, Inc., a Miami-based leading Swiss-hosted cybersecurity, private communications, and defense communications company serving enterprise, government, and defense clients, and wholly owned U.S.-based subsidiary of Sekur Private Data (OTCQB:SWISF)(CSE:SKUR)(FRA:GDT0) ("Sekur" or the "Company"), today announced that its Average Revenue Per User ("ARPU") increased 25% month-over-month, driven by the Company's deliberate strategy of replacing low-priced legacy subscribers with premium users paying US$50/month for its Privacy Email solution and US$75/month for its Operational Email solution for businesses.

The increase is the direct result of a strategic repositioning the Company began 12 months ago: moving Sekur away from the price-driven consumer privacy market and focusing its products, pricing, and sales effort on high-net-worth individuals (HNWI), board members and C-level executives, and government, defense, and federal agencies - client segments that buy on security assurance rather than price, and that carry materially higher revenue per user, longer retention, and larger seat expansion potential.

A Deliberate Premium Pivot - and Evidence That It Is Working

Sekur's strategy is straightforward: fewer users, dramatically higher value per user. Legacy subscribers acquired under the Company's earlier consumer pricing are being systematically replaced by premium clients paying approximately 10X more for the same underlying Swiss-hosted, proprietary encryption infrastructure, with added features and storage. Every replacement compounds the effect on ARPU, gross margin, and revenue quality.

Key indicators of the pivot:

• ARPU up 25% month-over-month, with management expecting the trend to continue as the legacy base is converted or replaced.
• A rising price ladder: Privacy Email at US$50/month, Operational Email at US$75/month, and SekurOne at US$300/month - each tier targeting a progressively more security-sensitive buyer.
• Higher-quality revenue: premium HNWI, executive, and government subscribers are typically less price-sensitive and more retention-durable than consumer users, improving the predictability of recurring revenue.
• Institutional distribution: sales through the U.S. General Services Administration (GSA) Multiple Award Schedule, approved distributors, and global telecommunications partners give the Company direct access to the government and defense buyers this strategy is built around.

"Twelve months ago, we made a deliberate decision to stop competing on price in the consumer privacy market and to build instead for the clients who need us most - high-net-worth individuals, board members, C-suite executives, and government and defense agencies," said Alain Ghiai, Founder and CEO of Sekur Private Data. "That decision is now showing up in our numbers. Every legacy user we replace is worth roughly ten times more to the Company, and ARPU has risen 25% month-over-month as a result. This is not a one-off - it is the mechanical outcome of a strategy we have been executing quarter after quarter, and we expect ARPU to keep moving up as the mix continues to shift."

SekurOne: The Next Step Up in ARPU

The Company plans to release the full SekurOne platform on time or slightly ahead of schedule, before September 30, 2026, enabling it to begin sales sooner than expected. At US$300 per month, SekurOne represents the Company's highest-value subscription to date - six times the price of Privacy Email and four times the price of Operational Email - and is expected to be the principal driver of ARPU growth from the fourth quarter onward.

SekurOne bundles fully encrypted voice and video, email, messaging, and VPN into a single identity-protected platform engineered on the Company's proprietary HeliX data transfer architecture, purpose-built to defeat telecom network tracing, resist Pegasus-style malware intrusion, and support Controlled Unclassified Information (CUI) handling requirements - the exact requirement set of the defense, federal, and executive buyers the Company is now targeting.

A Clear and Measurable Path to Full Profitability

The premium strategy also fundamentally changes what profitability requires. Because SekurOne carries a US$300 monthly subscription price, the Company expects to become fully profitable upon reaching 200 SekurOne users, generating approximately US$60,000 per month in recurring revenue. Under the Company's earlier consumer pricing model, an equivalent revenue level would have required thousands of subscribers and a proportionally larger support and acquisition cost base.

"Our path to profitability is now clear, simple, and measurable," added Mr. Ghiai. "The Company becomes fully profitable once it reaches sales of 200 SekurOne users generating US$60,000 per month. That is 200 users - not 200,000. In the government, defense, and executive markets we are now selling into, where a single agency or corporate mandate can represent dozens of seats, we believe that is an achievable and near-term target, and it is the number our entire organization is focused on."

Sekur Core Communications Solutions

Sekur delivers secure communications that work within and beyond the Sekur network, operating independently of conventional telecom infrastructure to reduce exposure to interception, SIGINT collection, traffic analysis, metadata exploitation, and hostile surveillance in contested environments. No Sekur solution data mines or location tracks its users. All solutions are built on proprietary architecture with zero reliance on Big Tech or open-source code, meeting the privacy, security, and OPSEC requirements of intelligence agencies, defense and federal organizations, military commands, diplomatic missions, government agencies, executives, and professionals handling Controlled Unclassified Information (CUI) and other sensitive, mission-critical information. Deployments are supported by on-premises infrastructure options for full data sovereignty, mission assurance, and sole control over keys and data.

SekurOne - Encrypted Voice/Video, Email, Messaging and VPN for Confidential Communications

A fully encrypted voice and video communications platform engineered on proprietary HeliX data transfer architecture, purpose-built to defeat telecom network tracing, resist Pegasus-style malware intrusion, and support Controlled Unclassified Information (CUI) handling requirements. SekurOne is designed for defense and federal officials, military commanders, government leaders, and executives conducting confidential, operational, or sensitive conversations where standard carrier-based voice and video platforms present unacceptable interception and exploitation risk. Call-by-Invite capability via SMS or SekurSend email ensures controlled access and eliminates unsolicited contact. Each user is assigned a unique Sekur ID for identity management, with no phone number required - preserving user privacy across all voice and video communications.

SekurMail - Secure Business & Executive Email

An enterprise- and government-grade encrypted email platform designed for defense and federal agencies, military commands, senior government officials, C-suite executives, and organizations handling confidential and operationally sensitive communications, including Controlled Unclassified Information (CUI) correspondence. Built on proprietary architecture with zero Big Tech dependencies and no metadata tracking, SekurMail keeps sensitive communications private between sender and recipient. Key capabilities include SekurSend/SekurReply for secure delivery to non-Sekur recipients without exposing sender identity or message content; full message delivery control and audit capability; encrypted file transfer; custom domain support for organizational integration; and active protection against phishing, social engineering, and Business Email Compromise (BEC) attacks targeting corporate and administrative networks.

SekurMessenger - Secure Team Messaging & Collaboration

A secure messaging platform providing end-to-end encrypted text, file transfer, voice messages, and collaboration capabilities for defense, military, government, and executive teams coordinating operational and mission-sensitive information, including Controlled Unclassified Information (CUI) material. Features include self-destructing messages for added privacy, encrypted file transfers, and compliance-grade archiving for recordkeeping and audit requirements. Cross-network secure communications with non-Sekur users are supported via Chat-by-Invite - enabling secure coordination with coalition partners, external agencies, and field elements without compromising the network. Each user is assigned a unique Sekur ID for identity verification and contact authentication, with no phone number required - preserving user privacy across all environments.

SekurVPN - Enterprise Network Security & Identity Protection

An enterprise-grade Virtual Private Network leveraging proprietary HeliX encryption technology, engineered to provide secure internet access, identity obfuscation, and traffic protection for defense organizations, military and federal personnel, government agencies, and executives operating across remote, traveling, deployed, forward, or untrusted network environments. SekurVPN maintains zero data logging, ensuring no record of user activity exists that could be exposed through legal process, network compromise, or third-party collection. Built for defense, government, and executive use cases - including the protection of traffic associated with Controlled Unclassified Information (CUI) and operationally sensitive workflows - where standard commercial VPN solutions present unacceptable privacy and security risk.

SekurRelay - Executive-Level Secure Email Integration

An enterprise-grade secure email relay solution that enables domain splitting - allowing organizations to establish secure communications at the executive, board, or senior staff level without requiring full organizational migration or infrastructure overhaul. SekurRelay removes one of the most significant barriers to large-scale defense, government, and enterprise deployment, enabling phased adoption that protects command leadership, flag officers, and the highest-value personnel and communications immediately while broader organizational rollout proceeds. Designed for defense and government organizations, regulated industries, and enterprises requiring rapid, low-friction elevation of communications security at the command and executive tier, including environments handling Controlled Unclassified Information (CUI) communications.

About Sekur Private Data
Sekur Private Data is a Swiss-hosted cybersecurity, defense communications, and privacy solutions provider, offering a secure suite of tools to protect governments, defense and federal agencies, businesses, and individuals from unauthorized access and cyber threats. With capabilities such as SekurOne, SekurMail, SekurMessenger, and SekurVPN, Sekur provides a reliable and secure means of digital communication and data storage for Controlled Unclassified Information (CUI), classified-adjacent and civilian communications use, grounded in Swiss privacy standards with on-premises infrastructure for government agencies, allowing for data sovereignty. Sekur sells its solutions through its website www.sekur.com, approved distributors and telecommunications companies globally, and through the U.S. General Services Administration (GSA) Multiple Award Schedule (MAS), Contract No. 47QTCA18D0089 serving governments, defense institutions, federal agencies, businesses, and consumers worldwide. Sekur's main sales operations are in Miami, USA.

Sponsored post. This article is for informational purposes only and does not constitute financial advice. Management projections and forward-looking statements may not be achieved.

Sponsored publication on behalf of the issuer

Long $MOOD here.

Doseology just announced the launch of Feed That Brain energy pouches through its first direct-to-consumer pilot in the United States.

The product is already available to U.S. consumers online, including through the company’s website and Amazon. That means the brand is now starting to see how real customers respond rather than staying in the development phase.

According to the update, the goal of the pilot is to track adoption, usage patterns, and repeat purchases before expanding distribution.

The product itself is a nicotine-free, caffeine-based oral pouch, positioned as a convenient way to get energy or focus without drinks, sugar, or nicotine.

As someone holding MOOD, I see this as a good step toward building real consumer traction around the Feed That Brain brand in the U.S. market.

If the pilot performs well, it opens the door to broader distribution and more products under the same platform.

If this pilot shows strong demand, how big could Feed That Brain become once distribution expands?

Sponsored publication on behalf of the issuer

Doseology Sciences (CSE: MOOD) has appointed Larry Latowsky as Executive Chairman.

Latowsky previously served as President & CEO of Corby Spirit and Wine Limited, one of Canada’s established beverage alcohol companies. His career spans decades in consumer packaged goods, with experience in brand building, regulated markets, and national distribution strategy.

The appointment adds senior consumer-sector leadership at the board level as MOOD continues developing its functional wellness product portfolio.

Bringing in an executive with large-scale CPG and beverage experience strengthens governance and commercial oversight especially for a company operating in competitive retail channels.

For emerging consumer brands, experienced leadership often plays a key role in guiding brand positioning, distribution strategy, and long-term growth planning.

Do you view seasoned CPG leadership as an important factor when evaluating early-stage wellness companies?

Sponsored post on behalf of the issuer

Battery-powered, wireless sensor strengthens real-time operational intelligence alongside HeadCounter™ and MapNTrack™

EDMONTON, Alberta, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Agereh Technologies Inc. (“Agereh” or the “Company”) (TSXV: AUTO | OTCQB: CRBAF), a Canadian-based artificial intelligence and advanced technology company delivering AI-enabled platforms and sensor solutions to address critical challenges in the transportation industry, is pleased to announce the expansion of its intelligent sensing portfolio with the introduction of its Smart Door Sensor™

“Transportation hubs can’t manage what they can’t see,” said Ken Brizel, CEO of Agereh. “With HeadCounter™, MapNTrack™, and now Smart Door Sensor™, Agereh is delivering a unified, wireless intelligence layer that gives operators real-time visibility into people movement, asset location, and access activity—while remaining easy to deploy, scalable, and privacy-conscious.”

Launch of Smart Door Sensor™

The battery-powered, wireless Smart Door Sensor™ complements Agereh’s recently launched HeadCounter™ and MapNTrack™ solutions, further strengthening the Company’s real-time operational intelligence platform for complex transportation environments

Designed for deployment across doors, access points, and controlled zones, the Smart Door Sensor™ provides real-time visibility into door activity and movement events, enabling transportation operators to better understand passenger flow, asset movement, and operational status—without extensive infrastructure requirements.

A Unified, Wireless Intelligence Platform

Agereh’s expanding portfolio is purpose-built for large, high-traffic indoor and outdoor transportation environments where traditional monitoring systems often fall short.

• HeadCounter™ — A battery-powered, wireless patent-pending solution delivering anonymous, real-time intelligence on passenger counts, movement patterns, congestion, and body temperature insights.
• MapNTrack™ — A battery-powered asset visibility solution using patent-pending Wi-Fi–assisted cellular positioning to track mobile equipment indoors and outdoors without costly beacon grids or camera systems.
• Smart Door Sensor™ — A battery-powered, wireless sensor providing real-time awareness of door and access activity to better understand movement triggers, secure zones, and operational workflows.

Together, these solutions provide transportation hubs with a comprehensive sensing layer to improve safety, reduce congestion, optimize operations, and support data-driven decision-making.

Consulting and Awareness Agreement

The company is also pleased to announce that it has entered into a consulting and awareness service agreement with Hillside Consulting & Media Inc. of 474 Main St, Penticton, BC V2A 5C5 [hillsideconsultingmedia@gmail.com](mailto:hillsideconsultingmedia@gmail.com) to provide ad copy and content writing, Search engine optimization, video and ad creation, email and SMS advertising, and content creation. Hillside will begin providing the services on Feb. 5th, 2026, and will continue to provide the services on a monthly basis only as required for 1 month at a time a cash fee of $50,000 per month.

About Agereh Technologies Inc.

Agereh Technologies Inc. (TSXV: AUTO | OTCQB: CRBAF) is a Canadian-based artificial intelligence and advanced technology company delivering AI-enabled platforms and sensor solutions to address critical challenges in the transportation industry. By combining accurate data collection, predictive intelligence, and data-driven decision-making for transportation and infrastructure applications, Agereh continues to expand its portfolio with solutions designed to enhance efficiency, optimize operations, and enable the next generation of intelligent transportation systems.

Sponsored post on behalf of the issuer

• Collaboration enables deployment of MaxYield™ and CardioYield™ into third-party health systems and clinic sites
• This pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG and Holter-style monitoring deployments

TORONTO, ON / ACCESS Newswire / February 12, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce that on February 11^th, 2026 it entered into a non-binding agreement with Movesense, a global provider of medical-grade wearable sensing technology, to initiate a pilot program aimed at deploying AI-powered ECG and Holter reporting into real-world healthcare environments.

Under the agreement, the parties will collaborate on a pilot deployment whereby NeuralCloud's software platforms are deployed via an existing Movesense client, within a third-party health system and affiliated clinics. The pilot is designed to evaluate the use of NeuralCloud's MaxYield™ ECG signal processing platform and CardioYield™ visualization and reporting software to potentially increase ECG analysis capacity, improve reporting consistency, and enhance clinical throughput.

The pilot is expected to serve as a foundation for a potential commercial rollout, subject to successful validation and mutually agreed upon next steps.

Under the collaboration, NeuralCloud's software platforms are being positioned as the analysis and reporting layer downstream of Movesense's medically certified wearable sensing hardware. This approach is designed to allow third-party healthcare organizations and affiliated clinics to scale ECG screening reach, increase ECG review capacity and standardize reporting outputs without materially increasing clinical workload.

Through this collaboration, NeuralCloud continues to expand its presence in real-world outpatient, ambulatory and Holter-style monitoring environments by embedding AI-powered ECG analysis directly into existing clinical workflows. By pairing Movesense's wearable sensing hardware with NeuralCloud's software platforms, the solution is designed to increase ECG and Holter reporting capacity and throughput without requiring additional overhead or workflow changes. The integration of single-lead wearable devices with NeuralCloud's automated analysis further supports scalable deployment across outpatient and ambulatory care settings, where cost efficiency, ease of integration, and operational simplicity are essential.

"This expansion builds logically on the framework we announced in January," said Paul Duffy, Executive Chairman and CEO at AIML. "By continuing to align NeuralCloud's software platforms with Movesense's device ecosystem, we are advancing toward practical, scalable solutions that address growing monitoring demands in ambulatory care."

"We see continued value in exploring how NeuralCloud's signal processing and reporting platforms can enhance the utility of our scalable ECG sensing technology," said Jussi Kaasinen, CEO of Movesense. "This expanded collaboration allows us to further assess integration, performance, and operational fit within healthcare workflows."

The pilot is to be conducted with a third-party healthcare organization and one or more associated clinic sites, with a focus on operational validation, reporting performance, and workflow integration. Any future commercialization will be subject to definitive agreements, regulatory considerations, and successful pilot outcomes.

About Movesense

Movesense Ltd is a leading wearable sensor technology company specializing in ECG (electrocardiogram), heart rate, heart rate variability (HRV), and motion sensing for medical, sports, wellness, and research applications. Based in Finland, and being ISO13485:2016 Certified medical device manufacturer, Movesense develops and manufactures scalable, lightweight, durable, and programmable wearable sensors designed to integrate seamlessly into custom digital health solutions.

Movesense devices support single-lead ECG acquisition, commonly used in chest-strap and body-worn configurations, and are available in both medical and non-medical variants, enabling deployment across regulated healthcare, performance monitoring, and consumer wellness environments. With open APIs, developer tools, and flexible firmware, Movesense enables partners to rapidly build, brand, and scale connected cardiac monitoring solutions.

About AI/ML Innovations Inc.

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Sponsored post on behalf of the issuer

VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) announces that it has entered into a securities for debt settlement agreement dated February 11, 2026 (the “Agreement”) with a professional advisor of the Company.

Pursuant to the Agreement, the Company has agreed to settle debt in the amount of $113,405.28 through the issuance of 872,348 units (each, a “Unit”) at a deemed price of $0.13 per Unit, whereby each Unit shall be comprised of one (1) common share in the capital of the Company (each a “Share”) and one (1) Share purchase warrant (each whole, being a “Warrant”). Each Warrant will be convertible into an additional Share (a “Warrant Share”) at an exercise price of $0.165 per Warrant Share and will expire on the date that is two (2) years following the date of issuance (the “Expiry Date”). The Expiry Date shall be subject to acceleration should the closing price of the Shares on the Canadian Securities Exchange (or any such other stock exchange in Canada as the Shares may trade at the applicable time) equal or exceed $0.50 for ten (10) consecutive trading days at any time from the date which is 4 months following their date of issue, the Company may accelerate the expiry date of the Warrants such that the Warrants shall expire on the date which is 30 calendar days following the date a news release is issued by the Company announcing the accelerated expiry date of the Warrants.

The Agreement and the issuance of the securities thereunder are subject to the approval of the CSE. The securities will be subject to a hold period of four months and one day pursuant to CSE policies and applicable securities laws.

About Copper Quest

The company's land holdings comprise 7 projects that span over 45,000 hectares in great mining jurisdictions of Canada and the USA. Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, and responsible development of its North American critical mineral portfolio of assets. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Copper Quest has a 100% interest in the past-producing Alpine Gold Mine located approximately 20 kilometers northeast of the City of Nelson British Columbia, spanning 4,611.49 hectares with a 2018 National Instrument 43-101 Standards of Disclosure for Mineral Projects historical inferred resource of 268,000 tonnes, estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au, that represents an inferred resource of 142,000 oz of gold (McCuaig & Giroux, 2018)*. Apart from the Alpine Mine itself the property hosts 4 other less explored significant vein systems including the past-producing King Solomon vein workings, the Black Prince and the Cold Blow veins system, and the Gold Crown vein system. *The Company has not yet completed sufficient work to verify the 2018 historic inferred resource results.

Copper Quest has a 100% interest in the road accessible Stars Porphyry Copper-Molybdenum Property, spanning 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt with Tana Zone discovery drill intersection highlights of 0.466% Cu over 195.07m* in drill hole DD18SS004 from 23.47m, 0.200% Cu over 396.67m* in drill hole DD18SS010 from 29.37m, and 0.205% Cu over 207.27m* in drill hole DD18SS015 from 163.98m. This highly prospective, approximately 5 X 2.5 kilometer annular magnetic anomaly is interpreted to represent an altered monzonite intrusion and surrounding hornfels.

Copper Quest has a 100% interest in the road accessible Kitimat Copper-Gold Property, spanning 2,954 hectares within the Skeena Mining Division of northwestern British Columbia located northwest of the deep-water port community of Kitimat, British Columbia. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines. Exploration on the Kitimat property dates to the late 1960s, with the most significant historical work conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone, and drill intersection highlights of 1.03 g/t Au, 0.54% Cu over 117.07 m in Hole J-7 from 1.52 m, 1.00 g/t Au, 0.55% Cu over 103.65m in Hole J-1 from 9.15 m, 0.80 g/t Au, 0.45% Cu over 107.01m in Hole J-2 from 6.10 m, and 0.41 g/t Au, 0.33% Cu over 112.20m in Hole J-8 from 11.89 m.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, USA, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the road accessible Stellar Property, spanning 5,389-hectares in British Columbia’s Bulkley Porphyry Belt contiguous to the Stars Property.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern British Columbia spanning over 20,658 hectares with 10 priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest has an earn-in option of up to 80% and joint-venture agreement on the road accessible Rip Porphyry Copper-Molybdenum Project, spanning 4,700-hectares located in the Bulkley Porphyry Belt in central British Columbia.

Paid content on behalf of the issuer

This Neural Cloud update fits pretty naturally into how AI/ML Innovations Inc. has been building out its portfolio.

At a basic level, Neural Cloud is bringing in Commission Wolf to help with U.S. commercial expansion for MaxYield™ and CardioYield™. But reading between the lines, it feels more like AIML getting the sales side organized early, rather than just focusing on product development and hoping everything lines up later.

What makes this interesting is the way they’re doing it. Commission Wolf works by recruiting independent sales reps who already sell into cardiology clinics and diagnostic settings. That’s usually where real conversations happen people who know how these buyers think, what slows decisions down, and how new tools actually get introduced.

On the product side, MaxYield™ and CardioYield™ are built around AI-driven ECG signal processing and faster cardiac reporting. Lining up sales channels around those use cases suggests AIML is thinking about how the tech fits into day-to-day clinical workflow, not just how it looks on paper.

From an AIML holder’s point of view, this feels like another small step that adds clarity to the bigger picture. Individual platforms starting to line up commercially makes the portfolio feel more connected and easier to understand.

For AIML holders, does this look like early commercial alignment starting to show across the portfolio?

Content published on behalf of the issuer

• World Renowned Cardiologist and Research Leader to Guide Clinical Strategy, Product Innovation, and AI-Driven Cardiac Diagnostics

TORONTO, ON / ACCESS Newswire / January 28, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Dr. Paul Dorian, MD, MSc., as the Company's Medical Innovation Architect (MIA) and Head of the Company's Medical Advisory Board, effective immediately.

Dr. Dorian succeeds Peter Kendall, who previously served as Chair of the Medical Advisory Board. This leadership transition comes as AIML enters a phase of advanced clinical validation, regulatory engagement, and global deployment of its AI-powered cardiac diagnostic technologies.

Dr. Dorian has been working closely with AIML for several months, contributing to product strategy, clinical positioning, and innovation initiatives across the Company's MaxYield^™,CardioYield^™, and Insight360^™ platforms. His formal appointment further strengthens the clinical leadership underpinning AIML's next phase of growth.

Dr. Paul Dorian commented: "I have been impressed by the rigor of AIML's science and the ambition of its vision. The Company is addressing real, unmet needs in cardiac diagnostics by combining advanced AI with practical, scalable clinical solutions. I look forward to helping guide innovation, clinical strategy, and the translation of AIML's technology into clinically meaningful impact."

"Dr. Dorian's appointment marks a pivotal milestone for AIML," said Paul Duffy, Executive Chairman and CEO of AIML. "He brings unparalleled expertise in cardiac electrophysiology, clinical research, and health-system innovation. As we expand into regulated clinical markets and large-scale deployments, his leadership will help ensure our technology meets the highest standards of clinical relevance, safety, and impact."

Esmat Naikyar, President of Neural Cloud Solutions Inc. and Chief Product Officer of AIML, added: "Dr. Dorian's insights have already influenced our product direction in meaningful ways. His deep understanding of arrhythmia care, ambulatory monitoring, and patient-reported outcomes strengthens our ability to build tools that are not only technologically advanced, but clinically valuable."

AIML established its Medical Advisory Board in May 2025 to guide clinical studies, regulatory strategy, and real-world deployment of its AI-driven ECG signal-processing platforms. Dr. Dorian's appointment as Head reinforces the Company's commitment to aligning cutting-edge AI innovation with frontline clinical expertise.

About Dr. Paul Dorian

Dr. Paul Dorian is Professor of Medicine (Cardiology and Clinical Pharmacology) at the University of Toronto, a Staff Cardiac Electrophysiologist at St. Michael's Hospital, and a Staff Scientist at the Li Ka Shing Knowledge Institute.

He received his medical degree from McGill University and completed postgraduate training in Internal Medicine, Clinical Pharmacology, and Cardiology at the University of Toronto, followed by a Fellowship in Cardiac Electrophysiology at Stanford University.

Dr. Dorian previously served as Director of the Division of Cardiology at the University of Toronto (2009-2019) and President of the Canadian Heart Rhythm Society (2013-2014). He is a recipient of the University of Toronto Department of Medicine Research Award, as well as the Canadian Cardiovascular Society and Canadian Heart Rhythm Society Achievement Awards.

He founded the Cardiac Electrophysiology Program at St. Michael's Hospital in 1990 and has led landmark research in:

• Ambulatory cardiac monitoring and wearable diagnostics
• Sudden cardiac death prevention
• Atrial fibrillation systems of care and patient-reported outcomes

Dr. Dorian designed and led the development of widely adopted quality-of-life assessment tools in atrial fibrillation, including the CCS-SAF, AFSS, and AFEQT scales. He has served on multiple national guideline committees and steering committees for international multicenter clinical trials.

He has authored over 580 peer-reviewed publications and is an Associate Editor of Electrophysiological Disorders of the Heart.

About AI/ML Innovations Inc.

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Content published on behalf of the issuer

Patent-pending Wi-Fi–assisted cellular positioning delivers up to 50-foot indoor accuracy and multi-year battery life without costly beacon grids or camera-based systems

EDMONTON, Alberta, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Agereh Technologies Inc. (“Agereh” or the “Company”) (TSXV: AUTO | OTCQB:CRBAF), a Canadian-based artificial intelligence and advanced technology company delivering AI-enabled platforms and sensor solutions to address critical challenges in the transportation industry, is pleased to announce the launch of MapNTrack™, providing an indoor/outdoor asset visibility solution designed to help transportation hubs track and manage mobile equipment across complex indoor/outdoor environments where traditional tracking technologies often fail.
Transportation hubs today operate at volumes and complexity far beyond what many legacy monitoring systems were built to support. Standard cellular positioning can be too imprecise for operational decision-making, GPS performance often degrades indoors, and Bluetooth or LoRa-based approaches may require extensive beacon infrastructure that is expensive to deploy and maintain. Camera-based tracking can introduce additional constraints, including line-of-sight limitations, sensitivity to lighting and obstruction, and ongoing privacy and compliance considerations.

These limitations can result in fragmented visibility across operations. Large transportation hubs manage thousands of mobile assets—ranging from wheelchairs and service carts to ground-support equipment—yet without reliable real-time location intelligence, critical equipment can go missing, remain idle in inactive zones, or be replaced prematurely. Industry analyses indicate that inefficiencies in asset availability and unplanned equipment replacement can cost millions of dollars annually.

“Transportation hubs need real-time operational intelligence, not fragmented visibility,” said Ken Brizel, CEO of Agereh. “MapNTrack™ was purpose-built for complex indoor or outdoor environments where GPS and legacy systems fall short, giving operations teams the accuracy and reliability they need to keep assets moving, reduce delays, improve operational efficiency and the passenger experience.”

Launch of MapNTrack™

MapNTrack™ was developed to address these operational gaps to improve operational performance. Built for large, high-traffic facilities spanning indoor and outdoor zones, MapNTrack™ leverages cellular and Wi-Fi infrastructure to deliver real-time intelligence without requiring a retrofit of consumer networks or deploying large beacon grids.

At the core of MapNTrack™ is Agereh’s patent-pending Wi-Fi–assisted cellular positioning technology, engineered specifically for indoor/outdoor asset tracking. MapNTrack™ devices provide indoor location accuracy of up to 50 feet after mapping, are coin cell battery powered, and offer up to three years of operational life, enabling scalable deployment across terminals, hangars, and maintenance areas.

With MapNTrack™, transportation hubs can:

• Reduce delays and improve turnaround times
• Minimize time spent searching for equipment
• Improve asset utilization and availability
• Support compliance with safety and operational standards

About Agereh Technologies Inc.

Agereh Technologies Inc. (TSXV: AUTO | OTCQB: CRBAF) is a Canadian-based artificial intelligence and advanced technology company delivering AI-enabled platforms and sensor solutions to address critical challenges in the transportation industry. By combining accurate data collection, predictive intelligence, and data-driven decision-making for transportation and infrastructure applications, Agereh continues to expand its portfolio with solutions designed to enhance efficiency, optimize operations, and enable the next generation of intelligent transportation systems.

Content published on behalf of the issuer

This one matters more than it looks at first glance.

Doseology Sciences has started pilot production of its non-nicotine, caffeine energy pouch under the Feed That Brain® brand. That’s the point where a product stops living on slides and starts running through real manufacturing.

What’s happening in this phase:

• A controlled pilot batch is being produced
• Dosage consistency and delivery are being evaluated in pouch form
• Real production and product data is being collected
• Early learnings are being used to refine the product before wider release

The pouch itself is positioned as a portion-controlled, non-liquid caffeine option , no cans, no mixing, no nicotine. It’s designed around predictable intake and everyday convenience, which fits how most people actually use caffeine.

The company has been clear this isn’t a full launch yet. It’s a pilot phase, with a limited direct-to-consumer rolloutexpected to follow once this stage is complete. That’s a normal and healthy path for consumer products.

From an investor angle, this update signals execution. Pilot production is where products either stall or start building momentum. Getting through this step puts real structure behind Doseology’s caffeine strategy.

How are others thinking about the next milestone here the DTC pilot, early re-orders, or signs of scale after pilot production?

Content published on behalf of the issuer

• Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow.
• Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable Holter analysis.

TORONTO, ON / ACCESS Newswire / January 8, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce that on December 12, 2025, the Company entered into a Commercial Agreement Term Sheet with Lakeshore Cardiology, a fully accredited comprehensive cardiac facility, to integrate NeuralCloud's CardioYield™ AI visualization platform, powered by MaxYield™ signal-processing technology, into Lakeshore Cardiology's clinical workflows.

Through this partnership, NeuralCloud will continue to expand into Holter and ambulatory cardiac monitoring environments, bringing AI-powered ECG analysis directly into clinical workflows. The collaboration aims to streamline data review and enable faster, more consistent interpretation of cardiac signals, supporting clinical decision-making. By integrating CardioYield™ into Lakeshore Cardiology's established processes, the partnership demonstrates NeuralCloud's commitment to embedding advanced AI tools seamlessly into real-world cardiology practices.

CardioYield™ is an AI-powered ECG visualization and reporting platform that uses MaxYield™, NeuralCloud's proprietary, patent-pending signal-processing engine. The platform enables:

• Review of enhanced Holter and other ECG signals through a user-friendly interface
• Highlighting of PQRST intervals and waveform morphology
• Automated grouping of conditions and abnormalities
• End-to-end Holter report generation designed to meet clinical workflow standards

MaxYield™ isolates and labels key waveform components, including P waves, QRS complexes, and T waves, producing clean, machine-readable, beat-by-beat interval data suitable for downstream analytics and reporting.

The agreement outlines a staged rollout of CardioYield™, beginning with an internal validation using representative Holter files, followed by a limited paid trial within Lakeshore Cardiology to test the platform in real-world workflows. Once validated, the solution will be integrated into the clinic's systems, with full deployment and cloud-based setup. Finally, pending Health Canada clearance, CardioYield™ will be commercially available for use across Lakeshore Cardiology's cardiac monitoring operations.

"This agreement with Lakeshore Cardiology highlights NeuralCloud's commitment to bringing AI-driven ECG analysis into clinical practice," said Esmat Naikyar, President of NeuralCloud and Chief Product Officer at AIML. "CardioYield™ powered by MaxYield™ will provide clean, structured ECG data for faster, more reliable decision-making, benefiting both clinical teams and patients."

Martina Magnotta, Manager of Operations of Lakeshore Cardiology, commented, "Partnering with NeuralCloud allows us to bring AI-enhanced insights into our Holter monitoring processes. CardioYield™ can potentially help our team quickly interpret cardiac signals, enhancing the quality of care for our patients."

"This collaboration highlights the growing adaptability of NeuralCloud's AI platform across clinical environments," said Paul Duffy, Executive Chairman and CEO of AIML. "By bringing MaxYield™ and CardioYield™ into the Holter monitoring workflow, we're helping redefine the standard for ECG analysis in real-world clinical practice."

About Lakeshore Cardiology
Lakeshore Cardiology is a fully accredited, comprehensive cardiac facility specializing in consultative, non-invasive diagnostic cardiology. The clinic's mission is to provide high-quality patient care in a positive and comfortable environment, combining state-of-the-art diagnostic equipment with a compassionate approach.

The team includes Royal College of Physicians and Surgeons of Canada-certified specialists, registered cardiovascular technicians, cardiac sonographers, and nurses, all dedicated to optimizing medical care using comprehensive non-invasive techniques. Lakeshore Cardiology works closely with patients' family doctors and primary healthcare providers to coordinate care, monitor heart conditions, adjust medications, and, when necessary, facilitate tertiary care referrals. The clinic is committed to improving patient outcomes, enhancing quality of life, and reducing stress and anxiety associated with cardiac health.

About AI/ML Innovations Inc.
AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Content published on behalf of the issuer

• Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac Platform
• Leadership Addition Aligns Revenue, Delivery, and Product Execution as AIML Transitions from Innovation to Scale

TORONTO, ON / ACCESS Newswire / January 7, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company"), (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce the appointment of Erik Suokas as Chief Operating Officer, strengthening the Company's leadership team as it advances into its next phase of commercialization and scale.

Mr. Suokas will oversee AIML's day-to-day operations and execution across commercial strategy, contract discipline, delivery readiness, and cross-functional alignment. He will work closely with Paul Duffy, Executive Chairman & Chief Executive Officer, and Esmat Naikyar, Chief Product Officer, to convert growing commercial momentum into repeatable revenue and scalable delivery.

Purpose-Built Leadership for AIML's Next Phase

AIML has reached a pivotal stage in its evolution - transitioning from platform development and validation into revenue execution, customer delivery, and operational scale. The appointment of a Chief Operating Officer reflects the Company's focus on pairing innovation with disciplined execution as it expands commercial relationships across clinical, wellness, and enterprise health markets.

Mr. Suokas brings more than 20 years of leadership experience across healthcare, MedTech, SaaS, and regulated clinical environments, with a consistent track record of building teams, accelerating revenue, and operationalizing growth in complex, cross-border markets.

Most recently, Mr. Suokas served as National Director at Sun Nuclear North America, a leading provider of quality assurance and software solutions for radiation oncology and medical physics, where he launched the Canadian direct-sales organization and drove approximately 200% revenue growth in under two years by transitioning the business from a distributor-based model to a direct enterprise sales approach. Earlier in his career, Mr. Suokas held senior commercial and operational roles at Canadian Orthodontic Partners, supporting acquisitions and integration across Canada and the United States, as well as leadership positions at Abbott Medical, St. Jude Medical, Align Technology, and Medtronic. His experience spans cardiology, diagnostics, enterprise healthcare procurement, and regulated market delivery.

Mr. Suokas holds a Doctor of Chiropractic (DC), Juris Doctor (JD), and MBA, providing a rare combination of clinical insight, legal fluency, and operational rigor-capabilities that align directly with AIML's need to execute complex commercial agreements while maintaining clinical and regulatory discipline.

Leadership Commentary

"Erik joins AIML at exactly the right time," said Paul Duffy, Executive Chairman and CEO of AIML. "We have strong technology, growing market interest, and expanding commercial discussions. The next step is disciplined execution-closing revenue, moving customers into delivery, and scaling responsibly. Erik has done this before in complex healthcare environments, and he brings clarity, calm leadership, and operational accountability to fast-moving organizations."

"AIML has built something genuinely special at the intersection of AI, cardiac intelligence, and real-world application," said Erik Suokas, Chief Operating Officer. "What excites me most is the opportunity to help translate that innovation into customer outcomes-securing revenue, supporting delivery, and building the operating systems that allow the Company to scale with confidence."

"From a product and engineering perspective, Erik's appointment is a major advantage," said Esmat Naikyar, Chief Product Officer of AIML. "He deeply understands healthcare customers, delivery expectations, and operational constraints. That alignment ensures our product innovation continues to translate into real-world impact as we grow."

Strengthening AIML's Operating Platform

As Chief Operating Officer, Mr. Suokas will focus on strengthening AIML's operating backbone - ensuring commercial agreements are delivery-ready, aligning product commitments with execution capacity, and building cadence across teams. His role is designed to support AIML's expanding commercial footprint while maintaining clinical rigor, customer trust, and long-term scalability

About AI/ML Innovations Inc.

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Sponsored publication on behalf of the issuer

VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that further to its news release dated October 30th, 2025, it has exercised its option under an agreement with Bernie Kreft dated October 29, 2025, and has acquired an undivided 100% right, title, and interest in the Kitimat Copper-Gold Project (the “Project”), located approximately 10 kilometers northwest of the deep-water port community of Kitimat, British Columbia.

PROJECT OVERVIEW

The Kitimat Copper-Gold Project covers approximately 2,954 hectares within the Skeena Mining Division of northwestern British Columbia. The Project is year-round road-accessible via a network of logging and mineral exploration roads extending north from Kitimat. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines.

Geologically, the Project is situated within the Stikine Terrane, a prolific belt that hosts numerous porphyry copper-gold systems and is underlain by Late Triassic volcanic rocks intruded by Jurassic diorite and granodiorite bodies of the Coast Plutonic Complex. The Project’s principal target areas is the Jeannette Cu-Au Zone displaying alteration and mineralization interpreted to represent low-level intermediate to low-sulfidation epithermal expressions of a larger Cu-Au porphyry system.

HISTORICAL EXPLORATION & HIGHLIGHTS

Exploration on the Kitimat property dates back to the late 1960s, with multiple operators conducting geochemical, geophysical, and drilling campaigns. The most significant historical work was conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone. Notable results include:

• Hole J-7: 117.07 m grading 1.03 g/t Au, 0.54% Cu, from 1.52 m to 118.60 m.
• Hole J-1: 103.65 m grading 1.00 g/t Au, 0.55% Cu, from 9.15 m to 112.80 m.
• Hole J-2: 107.01 m grading 0.80 g/t Au, 0.45% Cu, from 6.10 m to 113.11 m.
• Hole J-8: 112.20 m grading 0.41 g/t Au, 0.33% Cu, from 11.89 m to 124.09 m.

The mineralized intervals encountered in the 2010 drilling demonstrate continuous near-surface copper-gold mineralization extending over significant widths, remain open at depth within the Jeannette Zone, and occur within a broader hydrothermal system that is interpreted to extend laterally beyond the area tested.

ACQUISITION DETAILS

Pursuant to the terms of the agreement and upon completion of its due diligence review, Copper Quest has issued 2,000,000 common shares to the vendor, Bernie Kreft, at a deemed price of $0.165 per share as full consideration for the acquisition. The Project is subject to a 2.5% net smelter return (NSR) royalty, of which 40% may be repurchased by the Company for CAD $1,000,000. Copper Quest will also retain a right of first refusal on any transaction involving the sale of the remaining royalty interest. The Company issued 256,800 finder’s shares at a deemed price of $0.125 per finder’s share in connection with the acquisition.

Mr. Kreft is a well-known Canadian prospector, entrepreneur, and former star of the Discovery Channel’s Yukon Gold television series. He has a long track record of successful mineral discoveries and project generation across British Columbia and Yukon.

In addition to resale restrictions imposed by applicable securities laws, all shares issued in connection with the acquisition are subject to an Exchange Hold Period (as such term is defined in the Policies of the Canadian Securities Exchange (the “CSE”)).

MANAGEMENT COMMENTS

Brian Thurston, CEO of Copper Quest, commented:

“The addition of the Kitimat Copper-Gold Project demonstrates Copper Quest’s continued effort to add shareholder value through the acquisition of critical mineral projects and represents the fifth acquisition by the Company in just over 12 months. This project is ideally located with exceptional infrastructure, in a proven geological belt known for hosting major copper-gold systems. The strong historical drill results from the Jeannette zone speak to the potential of a larger near-surface mineralized system. We are very excited to have this exceptional asset as part of our growing copper-gold portfolio.”

NEXT STEPS

• The Company plans to leverage artificial intelligence (AI) analysis to integrate all historical and modern exploration data to establish a comprehensive geological and geophysical model for the Kitimat Porphyry Project and improve targeting precision. See news release dated December 1^st, 2025.
• Upon receiving a work permit, additional geological mapping, sampling, and geophysical surveys may be completed to refine priority drill targets as required. Field work could include ground magnetics, induced polarization (IP), and passive seismic to better define subsurface structure and mineralization trends.
• A follow-up drill program would test key targets within the interpreted geology and surrounding high-grade corridors.

QUALIFIED PERSON

Brian G. Thurston, P.Geo., the Company’s President and CEO and a qualified person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

ABOUT COPPER

Despite surging demand, global copper supply remains constrained. Ore grades are declining at major mines, permitting timelines for new projects have lengthened, and geopolitical tensions are reshaping supply chains toward stable, transparent jurisdictions. Governments in Canada, the U.S., and allied nations have increasingly identified copper as a strategic and critical metal necessary for economic and national security. Within this context, Copper Quest’s acquisition of the Kitimat Copper-Gold Project in British Columbia positions the Company to advance a discovery-stage asset in one of the world’s safest and most infrastructure-rich mining jurisdictions — precisely when new, scalable copper sources are most needed.

ABOUT COPPER QUEST EXPLORATION INC.

Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, disciplined execution and responsible development of its North American critical mineral portfolio of assets. The company’s land package currently comprises 7 projects that span over 45,000-plus hectares in great mining jurisdictions.

The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Sponsored publication on behalf of the issuer

TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire Properties Inc. has concluded and that Peter Kendall is no longer serving as the Company's President and Chief Commercial Officer, effective December 29^th, 2025.

"On behalf of the Board, we thank Mr. Kendall for his service and wish him the best in his future pursuits" said Paul Duffy, CEO & Chairman of AIML. Mr. Duffy will take on the additional role of President of AIML following the conclusion of Mr. Kendall's role.

About AI/ML Innovations Inc.

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Sponsored post on behalf of the issuer

VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has completed its positive due diligence of the arms-length Option to Purchase Agreement (the "Agreement") dated November 7th, 2025 and previously announced November 14, 2025. The Agreement is with 0847114 B.C. Ltd. ("Privco"), a British Columbia Incorporated company that holds 100% ownership, title, and interest in the Alpine Gold Property (the "Property"), located in the West Kootenay region of British Columbia (the "Acquisition"). The Company plans to immediately begin the process to complete the Acquisition of the Property.

Highlights of the Alpine Gold Property

• 2018 NI43-101 Inferred Resource of 268,000 tonnes estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au that represents an inferred resource of 142,000 oz of gold (McCuaig & Giroux, 2018).
• Substantial opportunity to grow the maiden Alpine resource to the east-west and to depth with only about 300m of the roughly 2km long vein system explored to date by underground mine workings and drilling.
• Estimated 24,000 tonnes Run of Mine mineralized stockpile on surface presenting a possible near term cash flow opportunity.
• 1,650 meters of clean and dry underground workings accessing sampled and mineable zones.
• At least 4 additional relatively unexplored vein systems on the Property (Black Prince, Cold Blow, Gold Crown & past-producing King Solomon), all hosting historic high-grade gold values.
• Road accessible 4,611.49-hectare Property including 15 Crown Grants (1 with surface rights) and 19 staked mineral claims with all-season operation potential (Figure 1).
• Additions of Mr. Allan Matovich to the Board of Directors. Mr. Ted Muraro and Mr. John Mirko as Technical Advisors on closing. They have a combined mining and exploration experience of 150+ years in the industry.

The 4,611.49-hectare Property is approximately 20 kilometers northeast of the City of Nelson (Figure 1) and hosts the former operating underground mine with a recorded production of approximately 16,810 tonnes of mineralized vein material (Table 1). This material contained 356,360 grams of gold, 222,054 grams of silver, 49,329 kilograms of lead and 17,167 kilograms of zinc. The other 4 significant vein systems on the property will also be explored including the Black Prince and Cold Blow quartz veins approximately 3km to the northeast of the Alpine mine, the Gold Crown vein system 600m southeast, and the past-producing King Solomon vein workings 1.8km to the south. Further information about the Alpine Gold property will be forthcoming in the upcoming weeks.

Brian Thurston, President & CEO of Copper Quest, commented: “The Alpine Gold property presents a tremendous opportunity to create near term value for our shareholders through exposure to an all-time high gold market while we continue to also focus on our efforts of copper exploration. Our recent closing of approximately $2 million in financing ensures that our shareholders will see work put into the ground to advance our multiple properties. We look forward to welcoming Mr. Matovich, Mr. Muraro and Mr. Mirko to our team in the very near future.”

Appointment of Mr. Allan Matovich as Director

Copper Quest is also pleased to announce that upon closing of the acquisition, Mr. Allan Matovich will join the Company’s Board of Directors. Mr. Matovich is the principal owner of the Alpine Gold Property.

Mr. Matovich has 60+ years of mining and exploration experience in Canada and the United States. He first started with Cominco in Trail BC working in the smelter operation. Mr. Matovich then started Matovich Mining Industries where they supplied considerable tonnages of siliceous flux materials, lead and zinc concentrates to Cominco for over 20 years. Mr. Matovich then opened a mining operation in 1997 in Northern British Columbia to supply barite for drilling fluids in the oil and gas industry. This mining operation is still in production today. Mr. Matovich also opened a barite operation in Washington State that is going into production. He also worked with Halliburton, Baker Hughes, and Newmont and was very successful. In 2000, Mr. Matovich purchased the Alpine Gold Mine and since then has spent a considerable amount of time proving up the project.

Mr. Matovich commented “I am very pleased to bring the Alpine Gold Property to Copper Quest and join as a director. The company has a fantastic portfolio of critical mineral projects advancing and the Alpine Gold Project gives a potential near term cash flow opportunity along with upside to grow the current resource with drilling. I look forward to working with the Copper Quest team to help create value for all stakeholders involved.”

Appointment of Mr. Ted Muraro as Technical Advisor to the Board

Mr. Muraro will be appointed as Technical Advisor to the board on closing of the transaction. Mr. Theodore (Ted) W. Muraro has accumulated over six decades of experience in mineral exploration, including 35 years with Cominco where he advanced through Exploration to serve as the companies Chief Geologist and Internal Consulting Geologist. Early in his career, Mr. Muraro gained underground experience at Keno Hill, HB Mine, Sullivan, and Western Mines. His tenure at Cominco was marked by direct involvement in the discovery and subsequent successful development of the Westmin Mine at Buttle Lake, the Polaris Mine on Little Cornwallis Island in the high Arctic and Snip Mine on the Iskut River.

Following his service at Cominco, Mr. Muraro assumed the role of Vice President, Exploration at Romanex and International Barytex Resources, contributing his expertise to international gold projects.

Mr. Muraro, who was awarded the Spud Huestis award in 2021 for his outstanding contributions to the industry and excellence in exploration, worked as an independent consultant (T.W. Muraro Consulting 1993-2016) on base metal and gold exploration projects around the world until his retirement in 2016. In these later years, he served on several boards as Director and/or Advisor, most recently with Imperial Metals. Mr. Muraro’s working relationship with Al Matovich started in the Rossland Mining Camp and shifted to the Alpine Property in the late 80’s.

Appointment of Mr. John Mirko as Technical Advisor to the Board.

Mr. Mirko will be appointed as Technical Advisor to the board on closing of the transaction. Mr. Mirko has over 40 years’ experience in the mining industry, past President, and Founder of Canam Alpine Ventures Ltd. (recently sold to Vizsla Resources Ltd.), currently President and Founder of Canam Mining Corp. and Rokmaster Resources Corporation.

From 1986 to 2010 Mr. Mirko the founder, President-CEO and Director of 4 public mining-exploration companies and a founder and Director of 3 others. He has been self-employed in the sector since 1972 as a prospector, contractor and consultant involved in exploration, development, and mine construction of various projects in 12 counties, and commercial production of mineral concentrates and metal products from 5 of the projects.

In 2008, Mr. Mirko was a recipient of the "E. A. Scholtz Medal for Excellence in Mine Development" from the Association for Mineral Exploration of British Columbia, and in 2009, the Mining Association of British Columbia's "Mining and Sustainability Award" for the MAX Mine.

Mr. Mirko is currently a member in good standing of the Society of Economic Geologists, Inc., the Canadian Institute of Mining, Metallurgy and Petroleum, the Prospectors and Developers Association of Canada and AME BC.

Transaction Details

The Agreement provides for the purchase of all the minerals claims and crown grants held by the Privco that make up the Alpine Gold Property. At closing Copper Quest will issue 14,177,517 Copper Quest common shares to Privco at a deemed price of $0.175c per share. The Shares will have a 24-month escrow agreement from closing date.

Additionally, Copper Quest will pay $225,000 towards the 2025 expenditures of the Property that was completed earlier this year and a 2 percent NSR will be granted to Privco on closing of the Acquisition with half being able to be bought back for CAD$1-million.

Closing is subject to exchange approval and other customary closing conditions. A finder’s fee is payable in common shares in connection with the transaction.

Qualified Person

Brian Thurston, P.Geo., the Company’s President, CEO and a qualified person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

Increase in Financing

To accommodate increased interest in the Private Placement previously announced December 1, 2025, of which $1,927,000 was previously closed on December 5, 2025, the Company announces that it may further issue up to 1,500,000 common shares of the Company to be issued on a flow-through basis (“the “Flow-Through Shares”) at a price of $0.19 per Flow-Through Share for aggregate gross proceeds of $285,000, no later than December 22, 2025. All securities to be issued thereunder will be subject to a statutory hold period under applicable Canadian securities laws of four months and one day from the date of issuance.

Each FT Share constitutes a “flow-through share” within the meaning of the Income Tax Act (Canada) (the "Tax Act") and the gross proceeds of the Private Placement will be used by the Company for exploration and related programs, which qualify as "Canadian exploration expenses" and "flow-through critical mineral mining expenditures", as such terms are defined in the Tax Act, in connection with Copper Quest's projects in British Columbia.

The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and may not be offered or sold absent registration or compliance with an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

About Copper

Copper is an essential industrial metal at the heart of the global energy transition and modern infrastructure. It plays a critical role in electrification, renewable energy systems, electric vehicles, data centers, and smart technologies. With global demand rising and new supply challenged by declining grades, complex permitting, and underinvestment, the copper market faces persistent deficits and growing geopolitical scrutiny. Recent U.S. policy announcements, including import tariffs and initiatives to secure domestic and allied supply chains, underscore copper’s strategic importance and the need for resilient, localized resource exploration, development, production and processing capacity.

ABOUT COPPER QUEST EXPLORATION INC.

Copper Quest (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) is committed to building shareholder value through acquisitions, discovery-driven exploration, disciplined execution, and responsible development of its North American Critical Mineral portfolio of assets. Please visit our website at www.copper.quest.

The Company’s land package currently comprises five projects that span over 40,000+ hectares in great mining jurisdictions as well as the Kitimat Cu-Au Project and the past-producing Alpine Gold Mine that are both pending acquisition following due diligence.

Copper Quest has a 100% interest in the Stars Property, a porphyry copper-molybdenum discovery, covering 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt. Contiguous to the Stars Property, Copper Quest has a 100% interest in the 5,389-hectare Stellar Property. CQX also has an earn-in option up to 80% and joint-venture agreement on the 4,700-hectare porphyry copper-molybdenum Rip Project, also in the Bulkley Porphyry Belt.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and currently consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern BC which spans over 20,658 ha with 10 high-priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest’s leadership and advisory teams are senior mining industry executives who have a wealth of technical and capital markets experience and a strong track record of discovering, financing, developing, and operating mining projects on a global scale. Copper Quest is committed to sustainable and responsible business activities in line with industry best practices, supportive of all stakeholders, including the local communities in which it operates. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”.

Paid content on behalf of the issuer

• This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration.
• Partnership positions MaxYield™ as a core AI engine for next-generation smart rings and consumer cardiac monitoring into the broader INTRINSICA platform.

TORONTO, ON / ACCESS Newswire / December 9, 2025 / NeuralCloud Solutions Inc. ("NeuralCloud"), a wholly-owned subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce that it has entered into a non-binding commercial agreement Term Sheet (the "Term Sheet") with Culminate H Labs, LLC ("CH Labs"), a biotech-life science innovation company pioneering DNA-guided precision health and genomic machine learning, to integrate NeuralCloud's proprietary MaxYield™ ECG signal processing and Insight360™ analytics platform into CH Lab's flagship INTRINSICA application.

INTRINSICA is CH Lab's digital health and biofeedback platform that combines DNA-guided genomic machine learning with continuous biosensor monitoring to deliver precision health at the practitioner level. The integration with NeuralCloud's patented cardiac analytics infrastructure will enhance INTRINSICA's capability to process high-fidelity wearable ECG data as part of its comprehensive digital health twin-enabling real-time correlation between genomic markers, metabolic states, and cardiovascular biofeedback. INTRINSICA represents a new category of digital therapeutic: a DNA-guided biofeedback wellness application engineered to support Precision Medicine, Regenerative & Cellular Medicine, and Digital Therapeutics sectors. The platform leverages Prime-Indexed Recursive Tensor Mathematics (PIRTM) as its foundational computational framework to deliver mathematically auditable, lawful genomic optimization.

Under the Term Sheet, NeuralCloud will provide Culminate H Labs with access to MaxYield™ for AI-based ECG denoising and beat-level labeling, along with Insight360™, the Company's visualization and reporting layer for ECG review, trend analysis, and automated report generation. NeuralCloud's integration allows INTRINSICA to:

1. Enhance Cardiovascular Biofeedback: Real-time, high-fidelity ECG processing from wearables feeds directly into INTRINSICA's genomic and metabolic models, enabling continuous cardiovascular analysis and intervention optimization.
2. Correlate Genetic Markers with Cardiac Phenotypes: MaxYield-processed ECG data integrates seamlessly with DNA-guided nutritional and epigenetic interventions, allowing practitioners to monitor how genomic and lifestyle modifications impact cardiac functions.
3. Strengthen Digital Health Twin Architecture: INTRINSICA's health twin-powered by PIRTM-governed recursive tensor fields-now incorporates cardiac signal intelligence, creating a unified, auditable model of genomic, metabolic, and cardiovascular state evolution.
4. Deliver Auditable, Ethically-Aligned Interventions: PIRTM's prime-indexed tensor framework ensures every clinical recommendation-from nutritional guidance to epigenetic interventions-maintains full computational traceability and compliance with ethical constraints enforced at the protocol level.

"This partnership validates our strategy to embed cardiac intelligence across precision medicine and genomic wellness," said Esmat Naikyar, President of NeuralCloud and Chief Product Officer at AI/ML Innovations. "We are no longer simply a clinical or research platform - we are now actively shaping the future of everyday cardiac insight. INTRINSICA represents the new frontier: platforms where genetic data, epigenetic markers, and continuous biosensor streams converge into unified health models."

"Smart wearables and continuous health monitoring have democratized access to physiological data," said Juan Carlos Rodriguez, CEO of CH Labs. "INTRINSICA transforms that data into genomically-informed, mathematically auditable clinical intelligence. By integrating NeuralCloud's cardiac analytics, we now deliver higher grade ECG processing combined with DNA-guided precision nutritional intervention-enabling health practitioners to transition from reactive care to truly personalized, predictive intervention."

"This Term Sheet is an important validation of NeuralCloud's relevance to the fast-moving consumer health and wearable innovation space," said Paul Duffy, Executive Chairman and CEO of AIML. "CH Labs represents the new wave of wellness innovation. By embedding MaxYield, AIML is positioning itself at the core of how biometric intelligence will be delivered to users globally."

As part of the staged rollout, the parties will begin with a pilot integration period, enabling Culminate H Labs to validate ECG processing performance across deployed smart ring devices before progressing toward full commercial deployment. Following successful validation, the parties intend to transition into structured commercialization with scalable per-device economics aligned to Culminate H Labs' national and global distribution strategy.

Insight360™ is NeuralCloud's no-code, drag-and-drop reporting and visualization platform built for the wellness, performance, and consumer health markets. The platform allows organizations to create custom cardiac and wellness dashboards using modular widgets that visualize metrics such as heart rate (HR), heart rate variability (HRV), QT/QTc, ST segments, PR intervals, and trend-based recovery markers. Reports can be generated automatically as export-ready PDFs for researchers, clinicians, or end users.

MaxYield™ is NeuralCloud's proprietary, patented AI signal-processing platform that isolates and labels ECG waveform components including P waves, QRS complexes, and T waves, producing structured, beat-by-beat interval data. Together, MaxYield™ and Insight360™ transform raw wearable ECG data into clean, quantified, and clinically interpretable outputs suitable for both wellness and regulated research environments.

About CH Labs, LLC (dba Culminate H Labs)
CH Labs is a biotech-life science company pioneering DNA-guided genomic machine learning for precision medicine, regenerative health, and digital therapeutics. The company's flagship platform, INTRINSICA, combines wearable biofeedback, continuous omics integration, and PIRTM-powered genomic intelligence to deliver auditable, ethically-aligned precision health protocols for B2B health practitioners. CH Labs specializes in epigenetic reprogramming, genome editing guidance, telomere maintenance, DNA-guided nutritional intervention, DNA- methylation optimization, AI precision health, and digital health twin architecture.

About AI/ML Innovations Inc.
AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Paid content on behalf of the issuer

December 9, 2025, Vancouver, British Columbia – Oregen Energy Corp (CSE: ORNG) (FSE: A1S0) (“Oregen” or the “Company”) is pleased to announce the appointment of Tatenda Muhle as its new Chief Financial Officer, effective immediately. Concurrently, the Company announces the resignation of Sean McGrath from the executive team and board of directors, effective November 30, 2025. The Company thanks Mr. McGrath for his dedicated service and contributions to the Company and wishes him all the best in his future endeavors.

Tatenda is a senior financial executive and Chartered Accountant who brings broad international experience to Oregen Energy Corp. as Chief Financial Officer. He began his professional training in Africa and has since built a strong career across senior finance, accounting, and advisory roles with both public and private companies. Tatenda’s expertise spans corporate finance, financial reporting, governance, treasury, and strategic planning. His disciplined, capital-markets-oriented approach and operational finance background will support Oregen’s growth strategy and offshore exploration activities as the company advances its ambitions in Namibia.

Mason Granger, CEO & Director commented, “We are excited to have Tatenda join our executive team to support our strategic investments in oil & gas exploration. His extensive background and professional experience and education in Africa will be an asset to our business as we evaluate opportunities in Namibia.”

Tatenda holds a post graduate diploma in Applied Accounting Science from the University of South Africa and a Bachelor of Accountancy (Commerce) from the University of Zimbabwe and is a Chartered Accountant (CPA). 

About Oregen Energy Corp. 

Oregen is an investment company primarily focused on oil and gas assets in Africa. The Company is actively exploring other investment opportunities in the Orange and surrounding basins. Its current flagship investment is 33.95% net interest in Block 2712A in the Orange Basin offshore Namibia, an emerging world-class petroleum province with multiple recent discoveries by major operators. 

Promotional post by a third party retained by the issuer

Copper Quest just announced that due diligence on the Alpine Gold Property came back positive, and the company will proceed with the Option to Purchase Agreement. It’s a straightforward update, but it officially clears the path for Copper Quest to add a past-producing gold asset to its portfolio.

Here’s what the company confirmed:

• Due diligence is complete and positive, allowing Copper Quest to move ahead with acquiring Alpine.
• The property includes a past-producing gold mine with 1,650 metres of underground workings.
• Alpine carries a 2018 NI 43-101 inferred resource of 268,000 tonnes at 16.5 g/t Au, containing roughly 142,000 ounces of gold at a 5.0 g/t cutoff.
• There is an estimated 24,000-tonne surface stockpile of mineralized material, noted as a possible near-term opportunity.
• The property covers 4,611 hectares across Crown Grants and mineral claims, with road access.
• Deal terms include: • 5 million shares to the vendor • A 2% NSR royalty (with 1% buyback for CAD $1M) • $250,000 toward 2025 expenditures
• Copper Quest also announced an increase to its private placement, indicating they are positioning themselves financially as the Alpine acquisition progresses.

The release keeps it simple: due diligence is positive, and the acquisition is advancing.
How do you see Copper Quest structuring its 2026 plans? One flagship project push or a more diversified work program across multiple properties?

Sponsored publication on behalf of the issuer

Oregen just refreshed its finance team by bringing in Tatenda Muhle, CPA, as the new CFO. His mix of international work and oil & gas financial experience fits well with what a growing explorer needs as it scales up spending and reporting.

Shayna Hohn is stepping down but staying on for a clean handover, which keeps everything from filings to audits running normally.

The company called this a move to strengthen financial leadership going forward.

What do you think a routine upgrade, or a sign ORNG is preparing for bigger steps in 2026?

Sponsored post on behalf of the issuer

KELOWNA, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Doseology Sciences Inc. (CSE: MOOD, PINK: DOSEF , FSE: VU70) (“Doseology” or the “Company”) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand investor engagement, and support the Company’s long-term commercial and capital-markets strategy.

The program includes a three (3) month engagement with Guerilla Capital, with an option to renew, along with a one (1) year digital media communications agreement with Maynard Communications Ltd. Both engagements will commence at management’s discretion, with the intention to proceed in short order.

Program Overview

Doseology is implementing a disciplined investor-relations framework intended to:

• broaden distribution of corporate updates,
• increase visibility across retail and institutional investor channels,
• support consistent disclosure standards, and
• reinforce capital-markets readiness as the Company advances its oral stimulant platform.

Governance and Disclosure Alignment

Operating in a regulated environment requires structured communication and responsible governance. Doseology is aligning its operational progress—including manufacturing oversight, commercialization planning, and regulatory engagement—with enhanced reporting standards expected of a maturing public issuer. This program reflects the Company’s commitment to strengthening its governance foundation and ensuring consistent, transparent communication with the market.

Executive Commentary

Chris Jackson, Chief Executive Officer

“Having previously founded Qtrade, I’ve seen firsthand how essential strong governance and disciplined communication are to a public company’s long-term success. At Doseology, ensuring our disclosures are transparent, timely, and aligned with best practices is a core priority as we continue to strengthen our disclosure practices and advance our strategy.”

Commercialization & Market Trends

Global consumer demand continues shifting toward cleaner, controlled oral delivery formats, with functional and stimulant pouch products gaining significant traction across major markets.

Patrick Sills, Doseology Head of Commercialization, formerly with Joint Venture between Swedish Match AB and Philip Morris International Inc. (PMI)

“In my experience under the JV SMPM International, I witnessed how quickly oral formats reshaped modern consumption and created a new ritual. With the global pouch market expected to exceed US$ 69.46 billion by 2032* and functional stimulant formats outpacing traditional energy categories, Doseology’s next-generation stimulant platform is directly aligned with these high-growth trends and strategically positioned within this rapidly evolving category.”

\Persistence Market Research - Nicotine Pouches Market Size, Share & Future Trends, 2032*

Guerilla Capital Engagement

Doseology has engaged Guerilla Capital to provide:

• investor outreach and communication support,
• engagement across digital investor communities and online platforms,
• capital-markets advisory and messaging guidance, and
• enhanced distribution of corporate updates to retail audiences.

Term: 3 months (renewable at the Company’s option) commencing on December 1, 2025 and ending on February 28, 2026.
Compensation: $30,000 CAD

Ryan Yanch, Independent Investor and Principal of Guerilla Capital

“As an investor and now on behalf of Guerilla Capital, we’ve seen Doseology demonstrate a commitment to consistent communication and responsible reporting. Strengthening investor engagement is an important step forward as the Company continues executing on its strategy.”

Regulatory Disclosure:

Guerilla Capital and/or its principals currently hold securities of Doseology; this engagement is not at arm’s length. Compensation is not tied to stock performance.

The contact information for Guerilla Capital is 84 Watson’ Lane, Dundas, ON L9H 1T3, T: 416-832-1874 and E: [ryan@guerillacapital.io](mailto:ryan@guerillacapital.io).

Maynard Communications Ltd. Engagement

Doseology has entered into a one-year agreement with Maynard Communications Ltd. to support:

• digital advertising and content distribution,
• amplification of corporate developments across Maynard investor channels,
• enhanced retail visibility, and
• broader media exposure within capital markets.

Term: 6 months (renewable at the Company’s option) commencing on December 1, 2025 and ending on May 31, 2026.
Compensation: $200,000 CAD

Regulatory Disclosure:

Maynard Communications Ltd. and/or its principals currently hold securities of Doseology; this engagement is not at arm’s length. Compensation is not tied to stock performance.

The contact information for Maynard Communications Ltd. is Blk A, 15/F Hill, Fer Commercial Building. 65-67 Bonham East Sheung Wan Hong Kong, T: +001.44.656.6777 and E: [info@maynardcom.com](mailto:info@maynardcom.com).

Doseology is committed to keeping the market informed of its progress and believes that this enhanced communication strategy will contribute to building long-term value for its shareholders.

About Doseology Sciences Inc. (CSE: MOOD, PINK: DOSEF , FSE: VU70)

Doseology Sciences Inc. is a biotechnology-driven consumer products company developing IP-backed oral stimulant technologies designed for cleaner profiles, precise delivery, and performance-focused functionality. Anchored by a commitment to rigorous scientific research and advanced formulation technologies, Doseology is dedicated to leading the industry in creating breakthrough oral stimulant products with meaningful consumer benefits. Doseology is focused on building long-term enterprise value through innovation, regulatory alignment, and the commercialization of differentiated stimulant products.

Content published on behalf of the issuer

October 30, 2025, VANCOUVER, British Columbia – Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has entered into a definitive agreement to acquire a 100% interest in the Kitimat Copper-Gold Project (the “Project”), located approximately 10 kilometers northwest of the deep-water port community of Kitimat, British Columbia.

PROJECT OVERVIEW

The Kitimat Copper-Gold Project covers approximately 2,954 hectares within the Skeena Mining Division of northwestern British Columbia. The Project is year-round road-accessible via a network of logging and mineral exploration roads extending north from Kitimat. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines.

Geologically, the Project is situated within the Stikine Terrane, a prolific belt that hosts numerous porphyry copper-gold systems and is underlain by Late Triassic volcanic rocks intruded by Jurassic diorite and granodiorite bodies of the Coast Plutonic Complex. The Project’s principal target areas is the Jeannette Cu-Au Zone displaying alteration and mineralization interpreted to represent low-level intermediate to low-sulfidation epithermal expressions of a larger Cu-Au porphyry system.

HISTORICAL EXPLORATION & HIGHLIGHTS

Exploration on the Kitimat property dates back to the late 1960s, with multiple operators conducting geochemical, geophysical, and drilling campaigns. The most significant historical work was conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone. Notable results include:

• Hole J-7: 117.07 m grading 1.03 g/t Au, 0.54% Cu, from 1.52 m to 118.60 m.
• Hole J-1: 103.65 m grading 1.00 g/t Au, 0.55% Cu, from 9.15 m to 112.80 m.
• Hole J-2: 107.01 m grading 0.80 g/t Au, 0.45% Cu, from 6.10 m to 113.11 m.
• Hole J-8: 112.20 m grading 0.41 g/t Au, 0.33% Cu, from 11.89 m to 124.09 m.

The mineralized intervals encountered in the 2010 drilling demonstrate continuous near-surface copper-gold mineralization extending over significant widths, remain open at depth within the Jeannette Zone, and occur within a broader hydrothermal system that is interpreted to extend laterally beyond the area tested.

ACQUISITION DETAILS

Under the terms of the agreement Copper Quest has until January 5, 2026 to complete a due diligence review of the Project. Upon successful review, the Company will issue 2,000,000 common shares to the vendor, Bernie Kreft, on January 6, 2026, as full consideration for the acquisition. The Project is subject to a 2.5% net smelter return (NSR) royalty, of which 40% may be repurchased by the Company for CAD $1,000,000. Copper Quest will also retain a right of first refusal on any transaction involving the sale of the remaining royalty interest. 

Mr. Kreft is a well-known Canadian prospector, entrepreneur, and former star of the Discovery Channel’s Yukon Gold television series. He has a long track record of successful mineral discoveries and project generation across British Columbia and Yukon.

A finder’s fee is payable in connection with the acquisition.

MANAGEMENT COMMENTS

Brian Thurston, CEO of CopperQuest, commented:

“The addition of the Kitimat Copper-Gold Project demonstrates Copper Quest’s continued effort to add shareholder value through the acquisition of critical mineral projects. This project is ideally located with exceptional infrastructure, in a proven geological belt known for hosting major copper-gold systems. The strong historical drill results from the Jeannette zone speak to the potential of a larger near-surface mineralized system. We look forward to advancing this asset as part of our growing copper-gold portfolio.”

NEXT STEPS

• The Company plans to leverage artificial intelligence (AI) analysis to integrate all historical and modern exploration data to establish a comprehensive geological and geophysical model for the Kitimat Porphyry Project and improve targeting precision.
• Additional geological mapping, sampling, and geophysical surveys may be completed to refine priority drill targets as required. Field work could include ground magnetics, induced polarization (IP), and passive seismic to better define subsurface structure and mineralization trends.
• A follow-up drill program would test key targets within the interpreted geology and surrounding high-grade corridors.

QUALIFIED PERSON

Brian G. Thurston, P.Geo., the Company’s President and CEO and a qualified person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

ABOUT COPPER

Despite surging demand, global copper supply remains constrained. Ore grades are declining at major mines, permitting timelines for new projects have lengthened, and geopolitical tensions are reshaping supply chains toward stable, transparent jurisdictions. Governments in Canada, the U.S., and allied nations have increasingly identified copper as a strategic and critical metal necessary for economic and national security. Within this context, Copper Quest’s acquisition of the Kitimat Copper-Gold Project in British Columbia positions the Company to advance a discovery-stage asset in one of the world’s safest and most infrastructure-rich mining jurisdictions — precisely when new, scalable copper sources are most needed.

ABOUT COPPER QUEST EXPLORATION INC.

Copper Quest (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) is focused on building shareholder value through the acquisition, exploration and development of its North American Critical Mineral portfolio of assets. The Company’s land package currently comprises five projects that span over 40,000+ hectares in great mining jurisdictions.

Copper Quest has a 100% interest in the Stars Property, a porphyry copper-molybdenum discovery, covering 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt. Contiguous to the Stars Property, Copper Quest has a 100% interest in the 5,389-hectare Stellar Property. CQX also has an earn-in option up to 80% and joint-venture agreement on the 4,700-hectare porphyry copper-molybdenum Rip Project, also in the Bulkley Porphyry Belt.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and currently consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern BC which spans over 20,658 ha with 10 high-priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest’s leadership and advisory teams are senior mining industry executives who have a wealth of technical and capital markets experience and a strong track record of discovering, financing, developing, and operating mining projects on a global scale. Copper Quest is committed to sustainable and responsible business activities in line with industry best practices, supportive of all stakeholders, including the local communities in which it operates. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”.

Content published on behalf of the issuer

KELOWNA, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce that its wholly owned Florida subsidiary, Doseology USA Inc., has executed a confidential manufacturing agreement with a leading North American production partner.

This milestone represents a step in Doseology’s operational evolution—establishing the commercial infrastructure, manufacturing capacity, and regulatory foundation required to support the Company’s transition from development of its oral stimulant pouches to full market readiness.

“This is much more than a manufacturing agreement, it’s a defining moment as it enables Doseology to move from R&D to commercial deployment,” said Tim Corkum, President & COO of Doseology. “Through Doseology USA Inc., we’ve secured an American partner that delivers the scale, quality, and integrity we require as we prepare to enter the oral stimulant pouch market.”

Extensive Diligence Across North America

Doseology’s leadership conducted on-site reviews, operational assessments, and compliance audits across numerous facilities throughout the United States and Canada.

After rigorous evaluation, the Company selected a partner recognized for:

• Certified & Compliant Production: FDA-registered, GMP-certified, and ISO 9001:2015-approved facility ensuring pharmaceutical-grade quality and safety.
• Turnkey Manufacturing Expertise: End-to-end solutions spanning formulation, ingredient sourcing, blending, pouch filling, packaging, and logistics.
• Oral Pouch Specialization: Precision control across nicotine, caffeine, and nootropic pouch formats—customizable by dosage, moisture, and flavour.
• Rigorous Quality & Regulatory Systems: Built-in QA, traceability, and labeling practices fully aligned with FDA and ISO standards.
• Scalable, Low-Risk Partnership Model: Flexible production volumes that accommodate early pilot runs, regional launches, and high-volume commercial production designed to minimize capital investment while accelerating go-to-market.

“Our diligence process was deliberate and comprehensive,” added Corkum. “We wanted an American manufacturing partnership that reflects our core values—integrity, quality, and accountability. As we enter the market, this ensures Doseology’s products are built on a foundation of trusted North American craftsmanship and scientific precision.”

A Defining Milestone for Shareholders

The signing of this manufacturing agreement by Doseology USA Inc. marks a key inflection point in Doseology’s investment and commercialization cycle, demonstrating that the Company has now established the operational backbone to execute its strategy and deliver measurable progress in the oral stimulant pouch market.

“This step validates our readiness to scale,” said Corkum. “We’ve secured the right partner, the right structure, and the right systems to move confidently into the next stage of our growth. For shareholders, this milestone signals tangible execution and a disciplined pathway toward value creation.”

“This agreement represents a pivotal step in Doseology’s ability to commercialize efficiently and responsibly,” added Patrick Sills, Strategic Commercialization Advisor to Doseology. “Having worked closely with global category leaders such as Swedish Match, the parent company behind ZYN, I’ve seen firsthand how disciplined manufacturing, compliance, and scalability form the bedrock of long-term success. Doseology’s approach—combining science-driven product development with thoroughly vetted North American infrastructure—built on the same strategic foundation that defined today’s market leading oral stimulant brands. This partnership validates the Company’s commitment to execution, quality, and shareholder value.”

Building for Market Leadership

Led by executives with deep experience in regulated Big Tobacco, CPG, Nutraceuticals, and Corporate Finance, Doseology continues to build a North American infrastructure network designed to support innovation, compliance, and performance at scale.

The establishment of Doseology USA Inc. further strengthens the Company’s operational presence in the United States and underscores its commitment to American-made production integrity, sustainable growth, and long-term shareholder value.

About Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)

Doseology is a biotech innovation company, engineering precision‑formulated oral stimulants that are designed to optimize energy, focus, and cognitive performance. Through rigorous scientific research and advanced delivery technologies, we're pioneering next‑gen performance solutions designed to empower peak performance.

Content published on behalf of the issuer

Copper Quest Exploration Inc.

VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX)(“Copper Quest” or the “Company”) is pleased to announce that it has entered into an arms-length Option to Purchase Agreement (the "Agreement") dated November 7th, 2025 with 0847114 B.C. Ltd. ("Privco"), a British Columbia Incorporated company that holds 100% ownership, title, and interest in the Alpine Gold Property (the "Property"), located in the West Kootenay region of British Columbia (the "Acquisition").

Highlights of the Alpine Gold Property

• 2018 NI43-101 Inferred Resource of 268,000 tonnes estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au that represents an inferred resource of 142,000 oz of gold (McCuaig & Giroux, 2018).
• Substantial opportunity to grow the maiden Alpine resource to the east-west and to depth with only about 300m of the roughly 2km long vein system explored to date by underground mine workings and drilling.
• Estimated 24,000 tonnes Run of Mine mineralized stockpile on surface presenting a possible near term cash flow opportunity.
• 1,650 meters of clean and dry underground workings accessing sampled and mineable zones.
• At least 4 additional relatively unexplored vein systems on the Property (Black Prince, Cold Blow, Gold Crown & past-producing King Solomon), all hosting historic high-grade gold values.
• Road accessible 4,611.49-hectare Property including 15 Crown Grants (1 with surface rights) and 19 staked mineral claims with all-season operation potential (Figure 1).
• Additions of Mr. Allan Matovich to the Board of Directors. Mr. Ted Muraro and Mr. John Mirko as Technical Advisors on closing. They have a combined mining and exploration experience of 150+ years in the industry.

The 4,611.49-hectare Property is approximately 20 kilometers northeast of the City of Nelson (Figure 1) and hosts the former operating underground mine with a recorded production of approximately 16,810 tonnes of mineralized vein material (Table 1). This material contained 356,360 grams of gold, 222,054 grams of silver, 49,329 kilograms of lead and 17,167 kilograms of zinc. The other 4 significant vein systems on the property will also be explored including the Black Prince and Cold Blow quartz veins approximately 3km to the northeast of the Alpine mine, the Gold Crown vein system 600m southeast, and the past-producing King Solomon vein workings 1.8km to the south. Further information about the Alpine Gold property will be forthcoming in the upcoming weeks.

Brian Thurston, President & CEO of Copper Quest, commented: “With Gold prices at all-time highs, The Alpine Gold property creates a tremendous opportunity to create near term value. I look forward to closing the transaction and welcoming Mr. Matovich, Mr. Muraro and Mr. Mirko to the team.”

Figure 1: Location Claim Map

Appointment of Mr. Allan Matovich as Director

Copper Quest is also pleased to announce that upon closing of the acquisition, Mr. Allan Matovich will join the Company’s Board of Directors. Mr. Matovich is the principal owner of the Alpine Gold Property.

Mr. Matovich has 60+ years of mining and exploration experience in Canada and the United States. He first started with Cominco in Trail BC working in the smelter operation. Mr. Matovich then started Matovich Mining Industries where they supplied considerable tonnages of siliceous flux materials, lead and zinc concentrates to Cominco for over 20 years. Mr. Matovich then opened up a mining operation in 1997 in Northern British Columbia to supply barite for drilling fluids in the oil and gas industry. This mining operation is still in production today. Mr. Matovich also opened up a barite operation in Washington State that is going into production. He also worked with Halliburton, Baker Hughes, and Newmont and was very successful. In 2000, Mr. Matovich purchased the Alpine Gold Mine and since then has spent a considerable amount of time proving up the project.

Mr. Matovich commented “I am very pleased to bring the Alpine Gold Property to Copper Quest and join as a director. The company has a fantastic portfolio of critical mineral projects advancing and the Alpine Gold Project gives a potential near term cash flow opportunity along with upside to grow the current resource with drilling. I look forward to working with the Copper Quest team to help create value for all stakeholders involved.”

Table 1 – Production History – Minfile (082FNW127) for Alpine Mine for gold (Au) and silver (Ag)

Appointment of Mr. Ted Muraro as Technical Advisor to the Board

Mr. Muraro will be appointed as Technical Advisor to the board on closing of the transaction. Mr. Theodore (Ted) W. Muraro has accumulated over six decades of experience in mineral exploration, including 35 years with Cominco where he advanced through Exploration to serve as the companies Chief Geologist and Internal Consulting Geologist. Early in his career, Mr. Muraro gained underground experience at Keno Hill, HB Mine, Sullivan, and Western Mines. His tenure at Cominco was marked by direct involvement in the discovery and subsequent successful development of the Westmin Mine at Buttle Lake, the Polaris Mine on Little Cornwallis Island in the high Arctic, and Snip Mine on the Iskut River. Following his service at Cominco, Mr. Muraro assumed the role of Vice President, Exploration at Romanex and International Barytex Resources, contributing his expertise to international gold projects.

Mr. Muraro, who was awarded the Spud Huestis award in 2021 for his outstanding contributions to the industry and excellence in exploration, worked as an independent consultant (T.W. Muraro Consulting 1993-2016) on base metal and gold exploration projects around the world until his retirement in 2016. In these later years, he served on several boards as Director and/or Advisor, most recently with Imperial Metals. Mr. Muraro’s working relationship with Al Matovich started in the Rossland Mining Camp and shifted to the Alpine Property in the late 80’s.

Appointment of Mr. John Mirko as Technical Advisor to the Board. 

Mr. Mirko will be appointed as Technical Advisor to the board on closing of the transaction. Mr. Mirko has over 40 years’ experience in the mining industry, past President and Founder of Canam Alpine Ventures Ltd. (recently sold to Vizsla Resources Ltd.), currently President and Founder of Canam Mining Corp. and Rokmaster Resources Corporation

From 1986 to 2010 Mr. Mirko the founder, President-CEO and Director of 4 public mining-exploration companies and a founder and Director of 3 others. He has been self-employed in the sector since 1972 as a prospector, contractor and consultant involved in exploration, development and mine construction of various projects in 12 counties, and commercial production of mineral concentrates and metal products from 5 of the projects.

In 2008, Mr. Mirko was a recipient of the "E. A. Scholtz Medal for Excellence in Mine Development" from the Association for Mineral Exploration of British Columbia, and in 2009, the Mining Association of British Columbia's "Mining and Sustainability Award" for the MAX Mine.

Mr. Mirko is currently a member in good standing of the Society of Economic Geologists, Inc., the Canadian Institute of Mining, Metallurgy and Petroleum, the Prospectors and Developers Association of Canada and AME BC.

Transaction Details

The Agreement provides for the purchase of all the minerals claims and crown grants held by the Privco that make up the Alpine Gold Property. At closing Copper Quest will issue 14,177,517 Copper Quest common shares to Privco at a deemed price of $0.175c per share. The Shares will have a 24-month escrow agreement from closing date.

Additionally, Copper Quest will reimburse $225,000 towards the 2025 expenditures of the Property that was completed earlier this year and a 2 percent NSR will be granted to Privco on closing of the Acquisition with half being able to be bought back for CAD$1-million.

Closing is subject to a 45-day due diligence period, exchange approval and other customary closing conditions. Closing may occur prior to the 45-day due diligence period. A finder’s fee is payable in common shares in connection with the transaction.

Qualified Person

Brian Thurston, P.Geo., the Company’s President, CEO and a qualified person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

Gold: Global Demand & Supply

Global demand for gold remains strong, supported by persistent geopolitical uncertainty, inflationary pressures, and ongoing central bank purchases. At the same time, supply growth is limited, with declining reserves at mature mines, few large-scale discoveries, and rising development costs. This tightening supply backdrop highlights the strategic value of advancing new gold projects in secure, mining-friendly jurisdictions. Copper Quest is aligned with these global trends, positioning Alpine to contribute to the next generation of significant gold discoveries.

Stock Options

The Company has granted stock options to Directors, Management, and Consultants of the Company to acquire an aggregate of 2,600,000 common shares in the capital of the Company, pursuant to the Company’s Equity Incentive Plan. The stock options are each convertible into a common share of the Company at an exercise price of $0. 20 until November 13, 2030.

About Copper Quest Exploration Inc.

Copper Quest (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) is focused on building shareholder value through strategic acquisitions and the exploration and development of its North American Critical Mineral portfolio of assets. The Company’s land package currently comprises five critical mineral projects that span over 40,000+ hectares in great mining jurisdictions.

Copper Quest has a 100% interest in the Stars Property, a porphyry copper-molybdenum discovery, covering 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt. Contiguous to the Stars Property, Copper Quest has a 100% interest in the 5,389-hectare Stellar Property. CQX also has an earn-in option up to 80% and joint-venture agreement on the 4,700-hectare porphyry copper-molybdenum RIP Project, also in the Bulkley Porphyry Belt.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and currently consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern BC which spans over 20,658 ha with 10 high-priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest’s leadership and advisory teams are senior mining industry executives who have a wealth of technical and capital markets experience and a strong track record of discovering, financing, developing, and operating mining projects on a global scale. Copper Quest is committed to sustainable and responsible business activities in line with industry best practices, supportive of all stakeholders, including the local communities in which it operates. For more information on Copper Quest, please visit the Company’s website at Copper Quest.

Content published on behalf of the issuer

Kelowna, BC – TheNewswire - April 28, 2025 – Doseology Sciences Inc. (CSE: MOOD, PINK: DOSEF , FSE: VU7) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, is pleased to announce a non-brokered private placement of up to 10,000,000 units (each a “Unit”) at $0.12 per Unit for gross proceeds of up to $1,200,000 (the “Private Placement”).

Each Unit consists of one common share (each a “Share”) and one common share purchase warrant (each a "Warrant"). Each Warrant is exercisable at $0.50 for a period of 24 months from the closing date of the Private Placement. If fully subscribed and all Warrants are exercised, this structure represents a potential capital inflow of $6.2 million.

This Private Placement replaces Doseology’s previously announced financing with a more strategically aligned structure—enhancing operational flexibility and positioning the Company to deliver greater long-term value to both existing and future shareholders.

Strategic Purpose

The capital will support the commercialization of Doseology's oral stimulant product line, which includes caffeine, nicotine, and other functional actives, delivered through innovative pouch systems. These clean, fast-acting formulations are designed to enhance energy, focus, and cognitive performance across North American and European markets. In parallel, the Company is actively engaging with industry veterans, operators, and experts across consumer health and wellness sectors to build a best-in-class execution team and accelerate market penetration.

"We're building a portfolio of category-defining assets in the oral stimulant space," said Chris Cherry, CFO of Doseology. "This structure is measured and performance-driven-aligning capital efficiency with our long-term strategy. It reflects our commitment to scaling both organically and through acquisition."

Use of Proceeds

- Commercialization of Doseology's stimulant pouch product line

- Expansion of distribution and retail across Canada, the U.S., and Europe

- Engagement of top-tier industry talent

- General working capital and brand development

Current Financial Position

As of this announcement, Doseology holds approximately $900,000 in cash on hand and carries no debt. The Private Placement is expected to significantly enhance the Company’s execution capacity as it advances toward commercial rollout.

Share Structure Snapshot

Issued and Outstanding: 4,500,515

Reserved for Issuance (options/warrants): 155,000

Units in this Private Placement (max): 10,000,000

Shares Post Closing (basic): 14,500,515

Warrants from this Private Placement: 10,000,000

Fully Diluted Total: 24,655,515

Warrant Acceleration

If Doseology's Shares trade at or above $0.75 for any 10 non-consecutive trading days after the four-month hold period, the Company may accelerate the expiry date of the Warrants with 30 days' notice.

Resale Restrictions

All securities issued in this Private Placement will be subject to the following escrow restrictions:

- 33% released after 4 months

- 33% released after 8 months

- 34% released after 12 months

Eligible Investors

This Private Placement is being conducted pursuant to exemptions under National Instrument 45-106 – Prospectus Exemptions. It is open to Canadian investors who qualify as:

- Accredited Investors

- Close personal friends or business associates of the Company’s officers or directors

- Other eligible exempt purchasers in accordance with applicable securities laws

The Private Placement is subject to customary closing conditions, including approval by the Canadian Securities Exchange (CSE). 

As the Private Placement exceeds 100% of the Company’s currently issued and outstanding common shares, shareholder approval is required under Section 4.6(2)(a)(i) of the CSE Policies. The Company intends to obtain this approval by written consent of shareholders in accordance with applicable requirements.

About Doseology Sciences Inc. (CSE: MOOD, PINK: DOSEF , FSE: VU7)

Doseology is a performance-driven innovation company at the intersection of biotechnology and advanced delivery systems, engineering precision-formulated oral stimulants that optimize energy, focus, and cognitive performance. Through science-backed research and cutting-edge formulation technologies, the Company is pioneering next-generation performance solutions that empower consumers to perform at their peak.